An international research team from Tanzania and Japan created a smartphone app and conducted a pilot study of how the app might be used to improve midwives’ knowledge and skills in Tanzania. Their study focused on the app’s potential effects on the learning outcomes of midwives and birth preparedness of pregnant women in Tanzania.
University of Maryland Medical Center, located in the healthcare hub city of Baltimore, receives national recognition for its academic maternal care units.
Women of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.
MEDSIR announced today the results of the PALMIRA trial. This randomized phase 2 study evaluated the safety and efficacy of palbociclib maintenance in combination with second-line endocrine therapy in patients with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer who had showed a confirmed progressive disease on first-line palbociclib plus endocrine therapy-based treatment after having achieved clinical benefit to this regimen.
Researchers at the Beckman Institute for Advanced Science and Technology found that early exposure to an environmental chemical called polychlorinated biphenyls, or PCBs, made it more difficult for mice to recover from sound-related trauma sustained later in life.
An observational cohort study out of Roswell Park Comprehensive Cancer Center demonstrates that race and ethnicity affect a woman’s 21-gene recurrence score, a tool used to determine risk of recurrence and distant metastasis in patients with early-stage, hormone-receptor-positive breast cancer. Based on the expression of 21 cancer-related genes detected in pre-treatment tumor specimens, recurrence score is used routinely in clinical care to identify patients who might benefit from chemotherapy as part of their treatment plan. Scores range from 0-100, with a score of 26 or higher indicating greater risk of recurrence and poorer overall survival.
Women ages 45 years and older taking estrogen hormone therapy in pill form were more likely to develop high blood pressure than those using transdermal (topical, applied to the skin) or vaginal formulations, according to new research published today in Hypertension, a peer-reviewed American Heart Association journal.
Two new discoveries from the Dudley lab at UVA Cancer Center highlight the different roles of blood vessels in solid tumors – and the findings could help prevent breast cancer from spreading and enhance the effectiveness of one of the most important new cancer treatments in many years.
Women's gymnastics has the highest rate of preseason concussion of all NCAA sports, with women gymnasts experiencing concussions at a rate 50% higher than football players.
New research led by an international team supported by the American Cancer Society shows women with an increasing number of regular mammography screening exams prior to diagnosis of breast cancer considerably improved their probability of survival. The findings were presented at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 2-6.
MEDSIR announced today the positive results of the PHERGain trial. This study is the first to use an adaptive design that tailors treatment in the neoadjuvant/adjuvant setting of patients with HER2-positive early breast cancer. The main objective of this trial was to assess the feasibility of a chemotherapy-free strategy based on a dual HER2 blockade with trastuzumab and pertuzumab through a positron emission tomography (PET)-based, pathologic complete response response(pCR)-adapted strategy.
A study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is added to hormone therapy there are significant survival benefits for patients with early hormone-receptor (HR) positive/HER2 negative breast cancer.
In addition to presenting Sylvester Comprehensive Cancer Center research findings, Sylvester experts are available at ASCO to share perspectives on a wide variety of topics and studies ranging from breast cancer to sarcoma, prostate cancer, mesothelioma, melanoma, CNS tumors and more.
As pesquisas sobre dissecção espontânea de artéria coronária aumentaram muito na última década, diz a Dra. Sharonne N. Hayes, cardiologista da Mayo Clinic e especialista principal nessa doença cardíaca rara.
La investigación sobre la disección espontánea de la arteria coronaria se ha disparado en la última década, dice la Dra. Sharonne N. Hayes, cardióloga en Mayo Clinic y experta destacada de esta afección cardíaca poco frecuente.
لقد كثرت الأبحاث في العقد الماضي حول التسلخ التلقائي للشريان التاجي، وتقول الدكتورة شارون إن. هايز، طبيبة القلب في مايو كلينك، وخبيرة رائدة في حالة القلب النادرة هذه.
Read about new melanoma treatment practices, how models provide information about a rare adrenal cancer, a potential oral medication for brain cancer, and clinical trials for cancer patients with HIV.
Todo lo que los médicos e investigadores saben acerca de la medicina, desde qué medicamentos recetar hasta cómo realizar las cirugías, se basa en la investigación. Pero durante décadas, la mayor parte de este trabajo ha dejado de lado a las participantes femeninas.
As part of a continued focus on making cancer screenings more accessible to the greater Philadelphia community, Penn Medicine is providing free cancer screenings, no insurance required, including advanced 3D mammograms, in West Philadelphia this June.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right